The nitric oxide synthase inhibitor. L-NAME, blocks certain phencyclidine-induced but not amphetamine-induced effects on behaviour and brain biochemistry in the rat

1. 1. The present experiments examined the effects of the nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), on some behavioural and biochemical effects of phencyclidine (PCP) and d-amphetamine (AMPH) in rats. Observation of behaviour was performed using a subjective scoring system. 2. 2. PCP (4 mg/kg) increased locomotor activity, rearing, sniffing, grooming and stereotyped behaviour, and decreased stillness. PCP also increased forepaw myoclonus, forepaw treading, head weaving, licking and chewing behaviour. Most of these behaviours were significantly suppressed by pretreatment with L-NAME (10 mg/kg). 3. 3. AMPH (1 mg/kg) exerted different effects on behaviour. It increased locomotor activity, rearing, sniffing, and stereotyped behaviour, and decreased stillness and grooming, but failed to affect the other behavioural items observed. Pretreatment with L-NAME did not counteract these effects. 4. 4. Ex vivo biochemical analysis indicated that PCP increased the tissue concentration of the dopamine (DA) metabolites, dihydroxyphenyl acetic acid (DOPAC) and homovanillic acid (HVA), in the ventral striatum (i.e., the nucleus accumbens and olfactory tubercles) and frontal cortex but not in the dorsal striatum. DA was not significantly affected in any of these regions. Furthermore, PCP increased the tissue concentration of the serotonin (5-HT) metabolite, 5-hydroxyindole acetic acid (5-HIAA), in a similar manner, while 5-HT was not affected. These biochemical effects were significantly counteracted by pretreatment with L-NAME. 5. 5. AMPH decreased tissue DOPAC concentration in the dorsal striatum, an effect which was not sensitive to pretreatment with L-NAME. However, the combined treatment with L-NAME and AMPH increased tissue DA concentration in all three regions investigated. 6. 6. The neurochemical and behavioural effects of PCP and AMPH were further investigated in an experimental model which allowed measurement of prepulse inhibition (PPI) of acoustic startle in parallel with in vivo microdialysis sampling of extracellular DA concentration in the brain of awake, freely moving animals. 7. 7. Both PCP (2 mg/kg) and AMPH (2 mg/kg) caused a significant decrease in PPI of similar magnitude and duration. These behavioural effects were accompanied by a significant increase in extracellular DA concentration in the nucleus accumbens (PCP: 213 ± 21% of basal concentration; AMPH: 563±117%). 8. 8. The decrease in PPI caused by PCP was blocked by pretreatment with L-NAME, but the change in DA concentration was not. Neither of these measures were significantly affected by L-NAME in AMPH-treated rats. 9. 9. In conclusion, this study shows that several behavioural and biochemical effects of PCP are prevented by pretreatment with the NOS inhibitor, L-NAME, while the effects of AMPH are less sensitive to this pretreatment. These observations emphasise the involvement of nitric oxide in the pharmacological effects of PCP.